FDA Wants Better Pregnancy Safety Data on Approved Drugs

(MedPage Today) — The FDA on Friday issued guidance for manufacturers collecting post-marketing data on the safety of approved drugs and biologics during pregnancy, in an effort to better understand potential risks to the pregnant patient and…